Insecticides (India) Limited

25 lakh

eading brands and strong Brand Equity of “TRACTOR BRAND” A rural FMCG like business model reaching 25 lakhs farmers with 7,500 distributors and 70,000 retailers State of the Art Manufacturing facilities wi

32%

* Under Toll Arrangement HAR KADAM HUM KADAM 3 Q4 & FY25 Highlights Strong Revenue Growth of 32% is registered in Q4FY25 as compared to Q4FY24 with significant improvement in profit margins across

13%

tent focus on value added premium products including Focus Maharatna and Maharatna , which grew by 13% in FY25. A robust performance was noted in Shinwa, Izuki, Mission SC, Mycoraja and new launches Gr

655 bps

Izuki, Mission SC, Mycoraja and new launches Gross Profit margin for FY25 stood at 32% improved by 655 bps driven by better product mix, improved pricing strategy and success of new launches EBITDA margin

281 bps

ct mix, improved pricing strategy and success of new launches EBITDA margins for FY25 improved by 281 bps with aggressive marketing campaign and field promotion to support premium products and new launche

18%

nd field promotion to support premium products and new launches ROCE and ROE improved for FY25 to 18% and 13% respectively, reflecting our strategic focus on profitability and efficient capital deploym

₹1,000

ient capital deployment Successfully completed a buyback of 500,000 fully paid-up equity shares at ₹1,000 per share, totaling ₹50 crore Acquired Kaeros Research Pvt. Ltd. to secure supply chains, reduce co

₹50 crore

ccessfully completed a buyback of 500,000 fully paid-up equity shares at ₹1,000 per share, totaling ₹50 crore Acquired Kaeros Research Pvt. Ltd. to secure supply chains, reduce costs through direct imports an

2%

HUM KADAM Healthy Product Mix Revenue B2C – Premium Vs Generic Sales by Segment (Rs in crs) 2% 1,966 2,000 FY24 FY25 Premium Generic 41% 59% FY24 39% 61% FY25 5% 26% 69% 5% 20%

41%

Premium Vs Generic Sales by Segment (Rs in crs) 2% 1,966 2,000 FY24 FY25 Premium Generic 41% 59% FY24 39% 61% FY25 5% 26% 69% 5% 20% 75% B2C B2B Exports FY24 FY25 Revenue B2C

59%

ium Vs Generic Sales by Segment (Rs in crs) 2% 1,966 2,000 FY24 FY25 Premium Generic 41% 59% FY24 39% 61% FY25 5% 26% 69% 5% 20% 75% B2C B2B Exports FY24 FY25 Revenue B2C – Pre

39%

ric Sales by Segment (Rs in crs) 2% 1,966 2,000 FY24 FY25 Premium Generic 41% 59% FY24 39% 61% FY25 5% 26% 69% 5% 20% 75% B2C B2B Exports FY24 FY25 Revenue B2C – Premium Vs Gen

“No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company.”

“said: “We are pleased to report a robust performance of the Company, marked by strong execution and strategic discipline, resulting in a profit growth of 39% in FY25.”

“This disciplined approach also led to an improvement in key return metrics, with both ROCE and ROE improving consistently even in FY25, a direct outcome of better product mix and efficient capital allocation.”

“We expect continued momentum supported by favorable macro tailwinds such as a strong monsoon forecast and stable raw material prices.”

“Recently we also launched Altair, a patented pre-emergent herbicide for paddy developed by Nissan Chemical Corporation, Japan, which will be exclusively marketed by us in India.”

Formulation Unit II

1

Upcoming Unit

1

Formulation and Technical Unit

1

COMPANY

1

INVESTOR RELATIONS ADVISORS

1

Investor Relations

1

Upcoming Unit

Sotanala Formulation Unit: Samba, Jammu and Kashmir Formulation Unit: Udhampur, Jammu and Kashmir Installed Capacity 30,000 KLPA Liquid 30,000 MTPA Granules 10,000 MTPA Powder 15,800 MTPA Active Ingredient and Intermediates Biological Unit*: Shamli, Uttar Pradesh All Manufacturing Sites in Govt Approved Industrial Estates Significant area available for Expansion at Dahej and Sotanala Multi purpose technical Plant with 20 different streams Overall capacity of the Technical Plant is 15,800 MT

Formulation and Technical Unit

Dahej, Gujarat Export Oriented Unit (SEZ): Dahej Gujarat Formulation plants with wide variety of formulations Overall capacity of formulation plant is more than 70,000 MT/KL per annum ~95% revenue from In-house Manufactured products. 100% Export oriented Formulation Plant in SEZ area. *Under toll arragreement HAR KADAM HUM KADAM *Total approved capacity 152220 MT/KL 35 35 Environmental and Social Governance 7.64% Solar Power plants contribute 7.64% of total electric consumption 30% Attained more than 30% Green Belt conforming to air quality standards Zero Implemented zero liquid discharge policy in 3 plants, (Chopanki, Samba & Udhampur) 1279.79 MT Successful disposal of hazardous waste Ensure effective usage of natural resources Reduce carbon footprint by adopting energy efficient manufacturing process Working on adopting zero liquid discharge (ZLD) policy across all our manufacturing units HAR KADAM HUM KADAM 36 CSR HAR KADAM HUM KADAM 37 Board Of Directors Mr. H.C. Aggarwal, Chairman

COMPANY

Insecticides (India) Limited CIN : L65991DL1996PLC083909 Sandeep Aggarwal (CFO) sandeep@insecticidesindia.com Email: sandeep@insecticidesindia.com www. insecticidesindia.com

INVESTOR RELATIONS ADVISORS

MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services MUFG (Investor Relations) bhavya.shah@in.mpms.mufg.com Mr. Bhavya Shah bhavya.shah@in.mpms.mufg.com masoom.rateria@in.mpms.mufg.com Ms. Masoom Rateria masoom.rateria@in.mpms.mufg.com For Meeting request - Click here Click here Thank You IIL Reports 85% Growth in PAT for Q4FY25 Delhi, May 28, 2025 : Insecticides (India) Limited (IIL), one of India’s leading crop protection and nutrition company, has announced its financial results for the quarter and full year ended March 31, 2025. Consolidated Financial Performance Particulars (Rs. Crs) Q4 FY25 Q4 FY24 Y-o-Y FY25 FY24 Y-o-Y Revenue from Operations 358.92 272.50 Gross Profit 131.36 86.84 32% 51% 1999.95 1966.39 640.83 501.36 2% 28% Gross Profit Margin (%) 36.6% 31.9% 32.0% 25.5% EBITDA EBITDA Margin (%) Profit After Tax Results Highlights 28.47 7.9% 13.89 8.73 3.2% 7.52 226% 221.22 162.32 36% 11.1% 8.3% 85% 142.02 102.07 39%

Investor Relations

MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services Mr. Bhavya Shah : +91 8082748577 bhavya.shah@linkintime.co.in Ms. Masoom Rateria : +918718991940 masoom.rateria@in.mpms.mufg.com CIN: L27106WB1987PLC042756 Mr. Sandeep Aggarwal Chief Financial Officer Email: sandeep@insecticidesindia.com www.insecticidesindia.com 3